VOLITIONRX LTD — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
VolitionRx filed an 8-K on 2026-09-15 disclosing an unregistered sale of equity securities (Item 3.02) with a report period of 2026-09-09. The filing header and XBRL data files are present, but the actual narrative document content—including counterparty identity, share count, dollar amount, and pricing—is not provided in the text supplied. Without these specifics, the materiality of this equity issuance cannot be assessed.
Why this rating
Cannot evaluate without pricing, share count, or dilution %. If unregistered sale, likely small or private placement. Routine disclosure unless transformational financing.
Extracted items
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.